These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3738247)

  • 21. Istaroxime: an investigational luso-inotropic agent for acute heart failure syndromes.
    Gheorghiade M; Sabbah HN
    Am J Cardiol; 2007 Jan; 99(2A):1A-3A. PubMed ID: 17239700
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current role of non-digitalis inotropic agents in acute and chronic treatment of heart failure].
    Dei Cas L; Nodari S; Raddino R; Metra M; Pelà G; Nardi M
    Cardiologia; 1994 Mar; 39(3):209-15. PubMed ID: 8039201
    [No Abstract]   [Full Text] [Related]  

  • 23. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS
    Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical studies with beta 2 adrenoceptor agonists in heart failure.
    Dawson JR; Bayliss J; Norell MS; Canepa-Anson R; Kuan P; Reuben S; Poole-Wilson PA; Sutton GC
    Eur Heart J; 1982 Dec; 3 Suppl D():135-41. PubMed ID: 6130947
    [No Abstract]   [Full Text] [Related]  

  • 25. [Differential therapy of chronic heart failure].
    Riegger AJ
    Internist (Berl); 1993 Oct; 34(10):939-43. PubMed ID: 8225843
    [No Abstract]   [Full Text] [Related]  

  • 26. [Acute hemodynamic and clinical effects of a new inotropic agent, levosimendan, in patients with severe heart failure].
    Porcu M; Orrù P
    Ital Heart J Suppl; 2001 Feb; 2(2):205-6. PubMed ID: 11255888
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of acute heart failure].
    Blanke H
    Internist (Berl); 1993 Oct; 34(10):929-38. PubMed ID: 8225842
    [No Abstract]   [Full Text] [Related]  

  • 28. [A preliminary study on the effect of oral amrinone in refractory congestive heart failure].
    Jiang J; Fu YS; Huang DJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1986 Jun; 14(3):142-4, 191. PubMed ID: 3536373
    [No Abstract]   [Full Text] [Related]  

  • 29. A new non-glycoside, non-adrenergic cardiotonic agent AR-L 115 BS. Hemodynamic proof of its efficacy after both i.v. and oral administration.
    Thormann J; Kramer W; Schlepper M
    Arzneimittelforschung; 1981; 31(1a):273-8. PubMed ID: 7195241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement by denopamine (TA-064) of pentobarbital-induced cardiac failure in the dog heart-lung preparation.
    Nunoki K; Goto T; Satoh K; Taira N
    Heart Vessels; 1985 Nov; 1(4):216-9. PubMed ID: 3831029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term denopamine therapy for hemodialysis patients with chronic heart failure.
    Takata Y; Tsuchihashi T; Nakamura S; Hirota Y
    Clin Cardiol; 1995 Jul; 18(7):408-11. PubMed ID: 7554546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New inotropic-vasodilating drugs in acute and chronic heart failure.
    Goenen MJ
    Ann Med Interne (Paris); 1986; 137(3):229-34. PubMed ID: 3767191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New aspects for therapy of chronic heart failure with positive inotropic substances].
    Erdmann E
    Verh Dtsch Ges Inn Med; 1991; 97():178-84. PubMed ID: 1808882
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of amrinone administered orally and by injection in heart failure].
    Bounhoure JP; Massabuau P; Puel J; Miquel JP; Calazel J
    Ann Med Interne (Paris); 1985; 136(3):251-5. PubMed ID: 3896092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neoton (exogenic phosphocreatinine) in combined therapy of chronic cardiac failure].
    Nedoshivin AO; Perepech NB
    Klin Med (Mosk); 1996; 74(9):45-8. PubMed ID: 9121090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM; O'Connor CM
    Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-digitalic cardiac inotropic agents].
    Méndez R
    Arch Inst Cardiol Mex; 1981; 51(3):201-5. PubMed ID: 7283531
    [No Abstract]   [Full Text] [Related]  

  • 39. Congestive cardiomyopathy: therapeutic approach.
    Chatterjee K; Stern L
    Compr Ther; 1982 Jul; 8(7):25-34. PubMed ID: 7116806
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pre-, intra- and postoperative heart failure: diagnosis, treatment strategies and control of effectiveness].
    Kromer EP
    Klin Anasthesiol Intensivther; 1995; 47():61-75. PubMed ID: 7715180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.